Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study

Ann Rheum Dis. 2006 Sep;65(9):1255-7. doi: 10.1136/ard.2005.051169. Epub 2006 Mar 15.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • B-Lymphocytes / drug effects*
  • Drug Resistance
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Rituximab
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Rituximab